Bibliometric analyses of innovation studies on the pharmaceutical industry
Angelo Romasanta is PhD candidate at VU Amsterdam (NL), Angelo studies the adoption and commercialization of innovation in the pharmaceutical industry. As part of the European project FragNet, her research explores how various firms and individuals created opportunities from the emergence of fragment-based drug discovery, an approach in the early stages of developing new drugs.
Hundreds of papers are published studying innovation in the pharmaceutical industry each year. What can scientists and managers in the industry learn from them? How can innovation scholars engage better with the industry? We present results of our bibliometric study, mapping these studies on innovation in drug discovery and development.